International Clinical Trial: A multicenter, prospective, basket interventional study of vixencizumab in the treatment of CAPS, FMF, Schnitzler syndrome and AOSD

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120336) titled 'A multicenter, prospective, basket interventional study of vixencizumab in the treatment of CAPS, FMF, Schnitzler syndrome and AOSD' on March 12.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Condition: AOSD, FMF, CAPS, and Schnitzler syndrome

Intervention: Cryopyrin-Associated Periodic Syndrome (CAPS):Firsekibart Adult-onset Still's disease (AOSD):Firsekibart Familial Mediterranean Fever (FMF):Firsekibart

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-20

Target S...